HELIUS MEDICAL TECHNOLOGIES, INC. HSDT Cash Flow

Helius medical technologies, inc. (HSDT)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14
Cash flows from operating activities:
Net income (loss)
-4,757	-5,331	-5,588	-186	1,324	-5,115	-4,517	-17,826	-1,165	-3,729	-12,938	-5,679	-5,678	-5,968	-2,986	-3,084	-3,830	-2,282	1,785	-2,554	-2,039	-2,478	-3,756	-1,563
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Change in fair value of derivative financial instruments
4	80	196	5,548	8,289	-221	368	-6,249	2,525	2,009	-5,960	1,024	-516	-1,458	288	-1,309	-30	-293	1,894	512	-68	-76	-594	0
Interest accretion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-0	5	-	-	-	-	-	-	-
Interest accretion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-176
Stock-based compensation expense
842	1,355	1,560	941	835	850	525	6,333	387	354	674	548	242	537	647	276	799	181	-209	460	370	1,032	603	333
Unrealized foreign exchange loss
-738	141	-58	23	-176	449	-23	292	993	173	-951	-697	-110	641	0	0	-780	472	545	-115	-	-	-	-
Depreciation expense
37	38	42	25	22	19	18	12	10	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-
Amortization expense
126	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision for doubtful accounts
139	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible asset impairment
174	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Accounts receivable
39	58	-166	-194	740	-	-	-	-	-51	-489	669	350	55	-362	133	270	9	95	15	6	1	0	0
Other receivables
-240	155	-84	123	84	269	-489	-167	-7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventory
-4	-691	387	171	339	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses
77	448	-140	-50	-95	347	-100	-58	-94	180	-171	-109	-86	-	-131	88	-	-	-141	22	-39	65	-24	108
Other assets
-	-	-	-	-	-	-	-	-	-18	0	0	18	-	-	-	-	-	-	-	-	-	-	-
Other current assets
-	-	-	-	-264	-	-	-	105	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating lease liability
-5	-4	-2	-4	-3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other current assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-32	-131	87	-292	-	-	-	-	-	-	-
Accounts payable
-626	-438	-1,333	572	83	187	664	-1,052	-886	-153	-207	73	1,605	-	-	-	-	-	-	-	-	-	-	-
Accrued liabilities
-459	-252	210	-141	-144	476	-85	-22	316	725	-50	-487	623	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-84	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-
Foreign exchange re-measurement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	222	0	0
Net cash used in operating activities
-3,751	-4,539	-5,246	-4,414	-6,800	-5,145	-3,348	-6,268	-4,860	-	-	-	-	-	-1,724	-2,368	-	-	-1,247	-2,146	-1,941	-1,620	-2,218	-540
Cash flows from investing activities:
Accounts payable and accrued liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	409	-648	359	175	-430	382	-	-	315	622
Shares to be issued
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	150	-	-	-	-	-	-	-
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-2,864	-3,792	-1,723	-2,369	-1,682	-	-	-	-	-	-	-
Purchase of property and equipment
3	18	56	43	161	15	226	172	27	9	66	115	0	-	-	-	-	-	-	-	-	-	-	-
Internally developed software
7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the sale of short term investment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	-378	378	0	0	0
Net cash used in investing activities
-10	-509	-56	-43	-161	-15	-226	-172	-27	-	-	-	-	-	0	0	-	-	0	378	-378	-173	0	173
Cash flows from financing activities:
Cash acquired on recapitalization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	23
Proceeds from the issuances of common stock and warrants
2,992	-	-	-	-	-	-	-	-	-	-	-	9,187	0	0	7,902	-54	5,000	312	2,519	-379	400	8	6,607
Proceeds from the issuance of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Share issuance costs
340	195	0	0	52	1,816	21	1,251	73	0	0	9	1,239	0	0	1,508	-0	0	16	124	-	379	0	0
Proceeds from the exercise of stock options and warrants
-	0	0	123	92	26	1	883	3,753	1,677	451	432	28	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	7,976	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of convertible debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1	0	0	633
Proceeds from exercise of stock options and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	96	1,397	-	-	0	0	-	-	-	-
Proceeds from bridge loan
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	150
Net cash provided by financing activities
2,652	1,490	0	123	40	18,336	-20	18,032	3,680	-	-	-	-	-	96	7,791	-	-	496	2,394	212	21	8	7,240
Effect of foreign exchange rate changes on cash
10	-2	10	-11	-6	10	4	0	40	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net decrease in cash
-1,099	-3,560	-5,292	-4,345	-6,927	13,186	-3,590	11,592	-1,167	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of foreign exchange rate changes on cash
-	-	-	-	-	-	-	-	-	32	316	-43	-115	179	-172	-93	-23	218	-28	-73	-380	-320	179	140
Net increase in cash
-	-	-	-	-	-	-	-	-	2,945	-4,242	-807	4,997	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,800	5,329	-1,706	4,158	-779	552	-2,487	-2,093	-2,030	7,014
Supplemental disclosure of non-cash cash activities
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	0	0	11	0
Cash paid for income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	0	0	0	0